(Q44138103)

30 November 2017

PET examination of [(11)C]5-methyl-6-nitroquipazine, a radioligand for visualization of the serotonin transporter (English)

1 reference

30 November 2017

1 reference

7

1 reference

30 November 2017

2

Christer Halldin

1 reference

30 November 2017

10

Lars Farde

1 reference

30 November 2017

Johan Sandell

1

1 reference

30 November 2017

Judith Sovago

3

1 reference

30 November 2017

Yuan-Hwa Chou

4

1 reference

30 November 2017

Balász Gulyás

5

1 reference

30 November 2017

Meixiang Yu

6

1 reference

30 November 2017

Kjell Någren

8

1 reference

30 November 2017

Denis Guilloteau

9

1 reference

30 November 2017

1 August 2002

1 reference

Nuclear Medicine and Biology

30 November 2017

1 reference

30 November 2017

29

1 reference

30 November 2017

6

1 reference

30 November 2017

651-656

1 reference

Serotoninergic terminal transporters are differentially affected in Parkinson's disease and progressive supranuclear palsy: an autoradiographic study with [3H]citalopram.

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900318-9

7 January 2021

High-affinity [3H]6-nitroquipazine binding sites in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900318-9

7 January 2021

PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporter.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900318-9

7 January 2021

Imaging the serotonin transporter with positron emission tomography: initial human studies with [11C]DAPP and [11C]DASB.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900318-9

7 January 2021

PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900318-9

7 January 2021

Characterization of bromine-76-labelled 5-bromo-6-nitroquipazine for PET studies of the serotonin transporter.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900318-9

7 January 2021

Inhibition of neuronal 5-HT uptake by ketamine, but not halothane, involves disruption of substrate recognition by the transporter.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900318-9

7 January 2021

Binding potency of 6-nitroquipazine analogues for the 5-hydroxytryptamine reuptake complex

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900318-9

7 January 2021

2-((2-((dimethylamino)methyl)phenyl)thio)-5-iodophenylamine (ADAM): an improved serotonin transporter ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900318-9

7 January 2021

The Palladium-Catalyzed Cross-Coupling Reactions of Organotin Reagents with Organic Electrophiles[New Synthetic Methods(58)]

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900318-9

7 January 2021

Positron emission tomography imaging of serotonin transporters in the human brain using [11C](+)McN5652

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900318-9

7 January 2021

Altered serotonin transporter sites in Alzheimer's disease raphe and hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900318-9

7 January 2021

Du 24565, a quipazine derivative, a potent selective serotonin uptake inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900318-9

7 January 2021

10.1016/S0969-8051(02)00318-9

Identifiers

DOI

1 reference

30 November 2017

1 reference